Wed.Jan 29, 2025

article thumbnail

Engineered muscle patch fixed failing hearts in an early study

STAT

By its name and nature, heart failure doesn’t have a good outlook. The progressive disease is diagnosed when the heart is no longer able to pump blood and oxygen throughout the body as well as it should, limiting daily activities and lifespan. Medications have improved at easing its symptoms, including obesity drugs that appear to work by reducing weight and fat, but researchers have long sought a more direct  repair of heart failure’s damage.

327
327
article thumbnail

EM Match Advice 46 | Program Directors Share Match Season Insights

ALiEM - Pharm Pearls

As interview season wraps up, medical students across the country are preparing their rank lists for the upcoming Match. EM Match Advice podcast host, Dr. Sara Krzyzaniak (Stanford EM Program Director) recently sat down with Dr. Melissa Parsons (University of Florida College of Medicine – Jacksonville EM Program Director), to discuss the match process from both program and applicant perspectives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: When your child can’t walk and it could be polio

STAT

My son was 5 years old when he climbed out of bed and landed on the floor. He was always a teaser. “C’mon, silly,” I said. “Time to get ready for school.” “Mommy,” Aaron said, very puzzled. “I can’t feel my legs.

Vaccines 341
article thumbnail

Executive hiring changes reflect a broader biotech comeback

PharmaVoice

Executive hiring shifts are often indicators of wider trends in the market. Here’s how the hiring landscape for pharma leaders is changing.

147
147
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Ozempic approved for chronic kidney disease patients

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Another busy day, so let’s get straight into the news.

article thumbnail

A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?

PharmaVoice

Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer alternatives to expand the pain management landscape.

147
147

More Trending

article thumbnail

Sustainability in Pharmaceutical Outsourcing

PharmaTech

Pharmaceutical Technology spoke with Saharsh Davuluri, Vice-Chairman and Managing Director, Neuland Laboratories, to see how the push to sustainability is impacting contract manufacturers.

106
106
article thumbnail

FDA clears use of Ozempic to protect kidney health

BioPharma Dive

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, which hasn’t yet proven it can improve outcomes in kidney disease.

Diabetes 101
article thumbnail

Industry Outlook 2025: Through the Lens of a Service Provider

PharmaTech

Pharmaceutical Technology spoke with Adam Sherlock, CEO of Qinecsa, about the industry trends of 2024, the future technology agenda, and M&A prospects in 2025.

105
105
article thumbnail

Ozempic is first GLP-1 drug FDA-approved for kidney disease

pharmaphorum

Novo Nordisk's Ozempic has become the first drug in the GLP-1 class to be cleared to prevent worsening kidney disease in type 2 diabetics

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How to develop GMP compliant software for quality management

GMPSOP

How to develop GMP compliant software for quality management Pharmaceuticals quality assurance & validation procedures GMPSOP %title% Prev PREVIOUS POST It has long been identified that if a pharmaceutical manufacturing business can automate its quality management systems using validated and reliable GMP compliant software applications, its productivity and compliance can improve in numerous ways.

article thumbnail

Lyfegen partners EVERSANA on pricing, access resource

pharmaphorum

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment

article thumbnail

RPS suggests 'opt-in' process for pharmacists participating in assisted dying

The Pharmacist

Pharmacists should be able to opt-in to participate in assisted dying by undertaking the necessary training, rather that having to opt-out of providing the service, the Royal Pharmaceutical Society (RPS) has told MPs. And it stressed that there must be no obligation for any pharmacist to participate in any aspect of assisted dying if they […] The post RPS suggests 'opt-in' process for pharmacists participating in assisted dying appeared first on The Pharmacist.

94
article thumbnail

OneSource gains EIR with VAI classification from USFDA for its BLD Facility

Express Pharma

OneSource Specialty Pharma announced that it has received an Establishment Information Report (EIR) with a Voluntary Action Indicated (VAI) status from the US. Food and Drug Administration (USFDA) for its BLD facility in Bengaluru. The report follows a comprehensive inspection of the facility, conducted from November 14 to November 22, 2024. OneSource operates five cGMP facilities and with 138 successful regulatory and customer audits to date by all major regulatory bodies.

96
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Pharmacists still most popular ARRS role, latest PCN figures indicate

The Pharmacist

Pharmacists continue to be the most popular role employed through the additional roles reimbursement scheme, latest monthly primary care workforce figures indicate. The NHS Digital data reports from the National Workforce Reporting Service (NWRS) submissions to give a picture of ARRS primary care network (PCN) staff across England. And its latest data set released this […] The post Pharmacists still most popular ARRS role, latest PCN figures indicate appeared first on The Pharmacist.

80
article thumbnail

Microbial therapy offers new hope for vitiligo patients

World Pharma News

A natural compound derived from gut-friendly bacteria significantly slows the progression of vitiligo and may restore pigmentation, reports a new Northwestern University pre-clinical study in mice. The findings could offer hope to millions affected by the autoimmune disease, which causes visible patches of skin discoloration and carries profound emotional and physical consequences.

article thumbnail

European Drug Shortage Monitoring Platform Fully Operational

PharmaTech

The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.

73
article thumbnail

Will European PFAS ban disrupt pharma supply chains?

Pharmaceutical Technology

A proposed ban on PFAS chemicals is being challenged over concerns about potential supply chain disruption in the pharmaceutical industry.

72
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Breaking Down the Cost of Generic Drug Production: Understanding the Factors Influencing Affordability

Drug Patent Watch

The Hidden Costs Behind Your Generic Medications: What's Driving the Price? As we navigate the complex world of healthcare, it's easy to overlook the intricacies of generic drug production. We often assume that generic medications are cheaper because they're, well, generic. But the truth is, there's more to it than meets the eye. The cost of producing generic drugs is influenced by a multitude of factors, and understanding these dynamics can help us better appreciate the affordability of these e

Dosage 78
article thumbnail

Troubled 23andMe is exploring a sale of the business

pharmaphorum

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.

66
article thumbnail

BioAge drops obesity drug; Akero, 89bio cash in on MASH data

BioPharma Dive

BioAge scrapped the drug at the center of its $198 million initial public offering last year. Elsewhere, Akero and 89bio raised $600 million combined and Allakos laid off staff.

61
article thumbnail

The future is LIVE marketing – and that matters more than ever

pharmaphorum

Discover why live marketing is the future, and why it matters now more than ever. Explore the latest trends, strategies, and tips for successful live marketing campaigns.

64
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Positive topline results announced in phase 2 Alcohol Use Disorder study

Pharmafile

Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has announced positive results for the phase 2a study into BPL-003 in patients with moderate-to-severe Alcohol Use Disorder (AUD). The study, labelled NCT05674929, was conducted at Kings College London and Clerkenwell Health, both UK.

article thumbnail

Budget expectations: Leaders opine for incentives in the nutra and API manufacturing sectors

Express Pharma

Priyanka Chigurupati, Executive Director, Granules India As India’s pharmaceutical industry cements its position as the world’s third-largest by volume, the upcoming Union Budget presents a crucial opportunity to accelerate our transformation into a global healthcare leader. With our industry projected to reach $120-130 billion by 2030, we must address the critical challenge of API dependency.

article thumbnail

Enhancing spectroscopy analysis with machine learning

European Pharmaceutical Review

Researchers have developed and optimised a novel sensing strategy for isomer discrimination by combining advanced spectroscopy with machine learning. The approach is based on surface-enhanced Raman scattering (SERS) substrates (ie, plasmonic platforms). Montes-Garca et al. explained that they fabricated advanced SERS substrates made of quasi-spherical gold nanoparticles (Au NPs) synthesised via a seeded growth method.

59
article thumbnail

FDA Approves Ozempic Indications for Reducing Risk of Kidney Failure, Cardiovascular Death

PharmaTech

Drug manufacturer Novo Nordisk said the approval establishes Ozempic as the most broadly indicated GLP-1 RA in its class.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

RFK Jr. denies being anti-vaccine during intense Senate confirmation

Pharmaceutical Technology

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his senate hearing.

article thumbnail

Hospital Readmissions: Reducing Costs with Innovative Solutions

PharmD Live

Hospital readmissions within 30 days of discharge are a critical issue in the U.S. healthcare system, placing financial strain on hospitals and negatively impacting patient outcomes. In 2023 alone, the average cost of a 30-day readmission reached $16,037 per patient, with certain conditions like heart failure and total hip or knee arthroplasty exceeding $27,000 per readmission.

article thumbnail

Upperton Pharma Solutions Finalizes Construction of Sterile Manufacturing Plant

Pharmaceutical Commerce

The 7,000 square-foot GMP facility will provide formulation development support, along with analytical testing services.

59
article thumbnail

Lantheus acquires radiopharma CDMO Evergreen for up to $1bn

Pharmaceutical Technology

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

59
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.